(Q42352441)

27 October 2017

Therapeutic exon 'switching' for dysferlinopathies? (English)

1 reference

27 October 2017

4

1 reference

27 October 2017

Nicolas Lévy

1

1 reference

27 October 2017

Nicolas Wein

2

1 reference

27 October 2017

Florian Barthelemy

3

1 reference

27 October 2017

Luis Garcia

5

1 reference

27 October 2017

Martin Krahn

6

1 reference

27 October 2017

Marc Bartoli

7

1 reference

27 October 2017

26 May 2010

1 reference

European Journal of Human Genetics

27 October 2017

1 reference

27 October 2017

18

1 reference

27 October 2017

9

1 reference

27 October 2017

969-70; author reply 971

1 reference

https://scigraph.springernature.com/pub.10.1038/ejhg.2010.73

27 October 2017

0 references

cites work

Progress in therapeutic antisense applications for neuromuscular disorders

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987414

Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping

29 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987414

Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEJHG.2010.73

Therapeutic exon skipping for dysferlinopathies?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEJHG.2010.73

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/EJHG.2010.73

1 reference

Dimensions Publication ID

27 October 2017

0 references

1 reference

27 October 2017

1 reference